Research output per year
Research output per year
Personal profile
Fields of Science
- 3121 General medicine, internal medicine and other clinical medicine
International and National Collaboration
Publications and projects within past five years.
-
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Borén, J., Taskinen, M-R. & Packard, C. J., 1 Aug 2024, In: Annual Review of Nutrition. 44, 1, p. 179-204 26 p.Research output: Contribution to journal › Review Article › peer-review
Open AccessFile -
Impact of therapeutic plasma exchange on intact protein S, apolipoproteins, and thrombin generation
Pitkänen, H. H., Haapio, M., Saarela, M., Taskinen, M-R., Brinkman, H-J. & Lassila, R., Jun 2024, In: Transfusion and Apheresis Science. 63, 3, 8 p., 103918.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Lipoprotein(a) Is Markedly More Atherogenic Than LDL An Apolipoprotein B-Based Genetic Analysis
Björnson, E., Adiels, M., Taskinen, M-R., Burgess, S., Chapman, M. J., Packard, C. J. & Boren, J., 23 Jan 2024, In: Journal of the American College of Cardiology. 83, 3, p. 385-395 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
Not enough known about fenofibrate's kidney effects in people with Type 2 diabetes
On Behalf of the FIELD Trial Study Group, Jenkins, A. J., O'Connell, R. L., Januszewski, A. S., Taskinen, M. R. & Keech, A. C., Apr 2024, In: Diabetes Research and Clinical Practice. 210, 3 p., 111612.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol
Björnson, E., Adiels, M., Gummesson, A., Taskinen, M-R., Burgess, S., Packard, C. J. & Borén, J., 1 Oct 2024, In: Journal of the American College of Cardiology. 84, 14, p. 1328-1338 11 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
Myocardial adipose tissue as new cardio-metabolic risk marker in patients with myocardial dysfunction.
Graner, M., Taskinen, M., Nieminen, M., Lundbom, N., Lauerma, K., Pentikäinen, M., Nyman, K., Siren, R., Hakkarainen, A., Lundbom, J., Nuutila, P. & Boren, J.
01/01/2009 → …
Project: Research project
-
The Finncad Study. Determinants of coronary and carotid atherosclerosis in Finnish patients with clinically suspected coronary heart disease.
Graner, M., Taskinen, M., Syvänne, M. & Nieminen, M.
01/01/2003 → 31/07/2007
Project: Research project
Activities
-
International Lipid Forum (External organisation)
Marja-Riitta Taskinen (Expert member)
8 Dec 2014 → 9 Dec 2014Activity: Membership types › Membership or other role in national/international committee, council, board
-
WHO Expert Working Group (External organisation)
Marja-Riitta Taskinen (Expert member)
9 Mar 2014 → 12 Mar 2014Activity: Membership types › Membership or other role in national/international committee, council, board
-
Swedish Foundation for Strategic Research Evaluation Committee for proposals in Novel biomarkers of clinical relevance (External organisation)
Marja-Riitta Taskinen (Chair)
10 Sept 2014Activity: Membership types › Membership or other role in national/international committee, council, board
-
Faculty of Health Sciences, Linköping University (External organisation)
Marja-Riitta Taskinen (Board member)
6 Feb 2014 → 7 Feb 2014Activity: Membership types › Membership or other role in national/international committee, council, board
-
German Centre for Diabetes Research evaluating meeting (External organisation)
Marja-Riitta Taskinen (Board member)
6 Nov 2014 → 7 Nov 2014Activity: Membership types › Membership or other role in national/international committee, council, board